Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed countries. However, some relevant safety concerns do exist in using furazolidone.
Zullo, A., Ierardi, E., Hassan, C., De Francesco, V., Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis, <<SAUDI JOURNAL OF GASTROENTEROLOGY>>, N/A; 18 (1): 11-17. [doi:10.4103/1319-3767.91729] [http://hdl.handle.net/10807/35636]
Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis
Hassan, Cesare;
2012
Abstract
Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed countries. However, some relevant safety concerns do exist in using furazolidone.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
